ESMO Members: Leukaemia and Myeloma: Essentials for Clinicians is available for download (PDF)
Multigene Sequencing in Breast Cancer and MGMT Promoter Methylation in Glioma
Haven't had much time lately? Here's what you may have missed in the last few weeks.
Sign-up to receive the OncologyPRO alert
every 2 weeks.
Find all 2018 ESMO Guidelines
, new Pan Asian Guidelines
and
discover the ESMO Guidelines Slide Sets
!
For full access to all OncologyPRO content: daily medwireNews, ESMO books, slides and webcasts... and much more.
Become an ESMO member today!
15 Feb 2019
The androgen receptor antagonist darolutamide achieved longer metastasis-free survival than placebo among men with castration-resistant prostate...
14 Feb 2019
Stereotactic ablative body radiotherapy may improve local control for patients with inoperable stage I non-small-cell lung cancer
13 Feb 2019
For patients with advanced HER2-positive breast cancer who have progressed on trastuzumab, combining the HER2 inhibitor with pembrolizumab may be an...
12 Feb 2019
An increased risk of fracture rules out the use of radium-223 with abiraterone acetate and steroids for the treatment of metastatic castration-resistant...
11 Feb 2019
Researchers recommend considering dose-intense chemotherapy regimens in early breast cancer patients after finding a significant reduction in recurrence...
In advanced prostate cancer, when patients become resistant to first-line classical androgen deprivation therapy, alternative options, besides chemotherapy, do exist.Abiraterone and Enzalutamide are recently developed hormonal treatments which have demonstrated benefit in survival. Ian Tannock explains how to use these drugs and when chemotherapy should be recommended in castration-resistant prostate cancer patients.
13-16 Dec 2018, Geneva, Switzerland
02-03 Dec 2018, Milan, Italy
26-27 Nov 2018, Singapore
26-27 Nov 2018, Singapore
23-25 Nov 2018, Singapore, Singapore
23-24 Nov 2018, Zurich, Switzerland
21-22 Nov 2018, Singapore
20-22 Nov 2018, Singapore
20-21 Nov 2018, Singapore
16-17 Nov 2018, Lugano, Switzerland
09-10 Nov 2018, Lisbon, Portugal
08-11 Nov 2018, Amsterdam, Netherlands
02-03 Nov 2018, Zurich, Switzerland
19-23 Oct 2018, Munich, Germany
06-08 Oct 2018, Lugano, Switzerland
